Suppr超能文献

视神经炎患者的大细胞和小细胞通路功能丧失。

Functional loss in the magnocellular and parvocellular pathways in patients with optic neuritis.

机构信息

Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, 1905 W.Taylor Street, Room 149, Chicago, IL 60615, USA.

出版信息

Invest Ophthalmol Vis Sci. 2011 Nov 17;52(12):8900-7. doi: 10.1167/iovs.11-7644.

Abstract

PURPOSE

To evaluate contrast threshold and contrast gain in patients with optic neuritis under conditions designed to favor mediation by either the inferred magnocellular (MC) or parvocellular (PC) pathway.

METHODS

Achromatic and chromatic contrast discrimination was measured in 11 patients with unilateral or bilateral optic neuritis and in 18 age-matched controls with normal vision, using achromatic steady- and pulsed-pedestal paradigms to bias performance toward the MC or PC pathway, respectively. In addition, L-M chromatic discrimination at equiluminance was evaluated using the steady-pedestal paradigm. A physiologically plausible model could describe the data with parameters accounting for contrast gain and contrast sensitivity in the inferred MC or PC pathway. The fitted parameters from the eye affected by optic neuritis were compared with those from the normal eye using generalized estimation equation (GEE) models that can account for within-subject correlations.

RESULTS

Compared with normal eyes, the affected eyes had significantly higher saturation parameters when measured with both the achromatic pulsed-pedestal paradigm (GEE: β [SE] = 0.35 [0.06]; P < 0.001) and the chromatic discrimination paradigm (β [SE] = 0.18 [0.08]; P = 0.015), suggesting that contrast gain in the inferred PC pathway is reduced; the affected eyes also had reduced absolute sensitivity in the inferred MC pathway measured with the achromatic steady-pedestal paradigm (β [SE] = 0.12 [0.04]; P = 0.005).

CONCLUSIONS

Optic neuritis produced large sensitivity losses mediated by the MC pathway and contrast gain losses in the inferred PC pathway. A clinical framework is presented for interpreting contrast sensitivity and gain loss to chromatic and achromatic stimuli in terms of retinal and postretinogeniculate loci contributions to detection and discrimination.

摘要

目的

评估视神经炎患者在设计条件下的对比阈值和对比增益,这些条件旨在有利于推断的大细胞 (MC) 或小细胞 (PC) 通路的介导。

方法

使用无彩色和彩色对比辨别测量了 11 名单侧或双侧视神经炎患者和 18 名年龄匹配的视力正常对照者,使用无彩色稳定和脉冲基底范式分别偏向于 MC 或 PC 通路的性能。此外,使用稳定基底范式评估等亮度下的 L-M 彩色辨别。一个生理上合理的模型可以用参数来描述数据,这些参数可以解释推断的 MC 或 PC 通路中的对比增益和对比敏感度。使用可以解释个体内相关性的广义估计方程 (GEE) 模型,比较受视神经炎影响的眼睛和正常眼睛的拟合参数。

结果

与正常眼睛相比,受影响的眼睛在使用无彩色脉冲基底范式 (GEE:β [SE] = 0.35 [0.06];P < 0.001) 和彩色辨别范式 (β [SE] = 0.18 [0.08];P = 0.015) 测量时,饱和度参数显著更高,表明推断的 PC 通路中的对比增益降低;受影响的眼睛在使用无彩色稳定基底范式测量时,推断的 MC 通路中的绝对敏感性也降低 (β [SE] = 0.12 [0.04];P = 0.005)。

结论

视神经炎导致 MC 通路介导的敏感性损失大,推断的 PC 通路中的对比增益损失。提出了一种临床框架,用于根据视网膜和视后神经节的贡献来解释对比敏感度和色觉和无彩色刺激的增益损失。

相似文献

1
Functional loss in the magnocellular and parvocellular pathways in patients with optic neuritis.
Invest Ophthalmol Vis Sci. 2011 Nov 17;52(12):8900-7. doi: 10.1167/iovs.11-7644.
3
Anisometropic amblyopia: spatial contrast sensitivity deficits in inferred magnocellular and parvocellular vision.
Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3622-31. doi: 10.1167/iovs.06-1207.
4
Assessment of contrast gain signature in inferred magnocellular and parvocellular pathways in patients with glaucoma.
Vision Res. 2008 Nov;48(26):2633-41. doi: 10.1016/j.visres.2008.04.008. Epub 2008 May 23.
9
Flicker adaptation desensitizes the magnocellular but not the parvocellular pathway.
Invest Ophthalmol Vis Sci. 2015 May;56(5):2901-8. doi: 10.1167/iovs.14-16067.
10
Magnocellular and Parvocellular Mediated Luminance Contrast Discrimination in Severe Alcohol Use Disorder.
Alcohol Clin Exp Res. 2021 Feb;45(2):375-385. doi: 10.1111/acer.14541. Epub 2021 Jan 29.

引用本文的文献

1
Evaluation of the modified critical fusion frequency test apparatus.
BMC Ophthalmol. 2025 Aug 18;25(1):470. doi: 10.1186/s12886-025-04270-x.
2
Visual perception alterations in COVID-19: a preliminary study.
Int J Ophthalmol. 2023 Jan 18;16(1):1-9. doi: 10.18240/ijo.2023.01.01. eCollection 2023.
3
Early-stage visual perception impairment in schizophrenia, bottom-up and back again.
Schizophrenia (Heidelb). 2022 Mar 21;8(1):27. doi: 10.1038/s41537-022-00237-9.
4
Retinal Ganglion Cells-Diversity of Cell Types and Clinical Relevance.
Front Neurol. 2021 May 21;12:661938. doi: 10.3389/fneur.2021.661938. eCollection 2021.
5
Selective Colour Vision Deficits in Multiple Sclerosis at Different Temporal Stages.
Neuroophthalmology. 2019 Jun 19;44(1):16-23. doi: 10.1080/01658107.2019.1615960. eCollection 2020 Feb.
6
More sensitive correlation of afferent pupillary defect with ganglion cell complex.
J Optom. 2018 Apr-Jun;11(2):75-85. doi: 10.1016/j.optom.2017.02.004. Epub 2017 Jul 1.
8
Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.
PLoS One. 2016 Jan 4;11(1):e0146084. doi: 10.1371/journal.pone.0146084. eCollection 2016.

本文引用的文献

3
Spatial contrast sensitivity in dynamic and static additive luminance noise.
Vision Res. 2010 Sep 15;50(19):1957-65. doi: 10.1016/j.visres.2010.07.006. Epub 2010 Jul 16.
4
Age-related changes in contrast gain related to the M and P pathways.
J Vis. 2010 Apr 13;10(4):4.1-15. doi: 10.1167/10.4.4.
5
Rod and cone contrast gains derived from reaction time distribution modeling.
J Vis. 2010 Feb 12;10(2):11.1-15. doi: 10.1167/10.2.11.
6
Magnocellular and parvocellular pathway mediated luminance contrast discrimination in amblyopia.
Vision Res. 2010 May 12;50(10):969-76. doi: 10.1016/j.visres.2010.03.002. Epub 2010 Mar 6.
7
Spatial summation properties for magnocellular and parvocellular pathways in glaucoma.
Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1221-6. doi: 10.1167/iovs.08-2517. Epub 2008 Oct 20.
10
Rod contributions to color perception: linear with rod contrast.
Vision Res. 2008 Nov;48(26):2586-92. doi: 10.1016/j.visres.2008.05.001. Epub 2008 Jun 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验